GAITHERSBURG, Md. (AP) – MedImmune, a unit of drug maker AstraZeneca PLC, said that it expects to ship between 15 million and 16 million doses of its three-strain influenza vaccine for the upcoming flu season.
The company has already begun shipping its FluMist nasal spray to distributors that service health care providers across the U.S.
MedImmune says data show that taking the vaccine as early as late summer helps protect against influenza throughout the flu season.
Date: July 18, 2011
Source: Associated Press
Filed Under: Drug Discovery